Medically reviewed by Renita White, MD Cancer that develops in the ovaries (the egg-producing reproductive organs) is ...

Researchers at the University of Pittsburgh have found special high-risk cells in the fallopian tubes that may trigger ...

Researcher suggests compounds secreted by high-risk MSCs that are detectable in the bloodstream could act as biomarkers for ...

Your doctor may give you a CA 125 blood test if you’ve gone through menopause. This test can’t tell the doctor whether you have ovarian cancer, but can give them a better sense of your risk ...

In view of the possibility that the ovarian mass was a carcinoma, however, the tumor markers CA-125 and CA-19-9 were also ordered, and a gynecological oncology consult requested. The gynecological ...

Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with platinum-resistant ovarian cancer (PROC) and continues to demonstrate ...

The late-breaking oral presentation at SGO 2025 highlights consistent response rates observed in patients across all levels of FRα expression of 25% or ...

Meanwhile, still others worry about increased health risks—for conditions such as osteoporosis, heart disease, and ...

New poster to highlight preclinical data of CER-1236 in ovarian cancer SOUTH SAN FRANSCISCO, Calif., March 05, 2025 (GLOBE ...